DESERT SHIELD MEDICAL ISSUES REVIEW AND AD HOC WORKING GRP

File: 110596_sep96_decls15_0002.txt
Page: 0002
Total Pages: 4

Subject: DESERT SHIELD MEDICAL ISSUES REVIEW AND AD HOC WORKING GRP      

Unit: OTSG        

Parent Organization: HSC         

Box ID: BX003202

Folder Title: DESERT SHIELD MEDICAL ISSUES REVIEW AND AD HOC WORKING GROUP                                    

Document Number:          1

Folder SEQ  #:         31







          SGPS-CP                                                2 7 DEC 1990


          SUBJECT: Minutes of the Desert Shield Medical Issues Working
          Group


          1. The Desert Shield Medical Issues Working Group was convened
          at 1100, 21 December 1990 in Room 691, Office of the Surgeon
          General. The following were present:

               COL Kussman, SGPS-CP-M, Chairperson
               COL Tomlinson, SGPS-PSP
               COL Bancroft, USAMRDC
               COL Pick, SGPS-CP-L
               COL Erdtmann, SGPS-PSP
               LTC Wright, HQ USAF/ SGPA
               LTC Falkenheiiner, HQ USAF/ SGHR
               LTC Lyon-Dean, BLO, DASG-HCO
               CDR Paleologo, NMRDC

          2. The  committee reviewed the recommendations of the
          Tri-service vaccine Task Force (encl).

               a. Cholera vaccine. COL Bancroft stated that there are two
          producers of cholera vaccine. He stated that the new oral
          vaccine is much more effective than the previous vaccine. The
          vaccine recommended by the tri-service committee has been tested
          on                               USAMRDC is negotiating to
          purchase                         ost of $8 million. COL
          Bancroft stated that MRDC would buy what the manufacturer has on
          hand and buy the rest as available. Committee members asked the
          following questions:

               (1) Can we field it fast enough? Will it be available by
          mid-January?

               (2) What is the likelihood of the FDA waiving the informed
          consent requirement?

          COL Bancroft stated that he would get availability data, shelf
          life, etc. to present to BG Blanck and TSG for decision on
          whether to pursue purchase of vaccine.

               b. Typhoid TY21a vaccine. - COL Bancroft stated that
          nothing has been done on this vaccine since all soldiers are
om AFEB. He
          stated that this vaccine may be good in basic training for the
          long term but not      for the immediate situation.

               c. Hepatitis A. COL Bancroft stated that this vaccine
          requires a series of immunizations. COL Kussman said that it is
          impractical to give a series of immunizations in Saudi Arabia.
          Committee members agreed that the vaccine could be used for

Document 4 f:/Week-36/BX003202/DESERT SHIELD MEDICAL ISSUES REVIEW AND AD HOC WORKING GROUP/desert shield medical issues review and ad hoc w:11049609101516
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003202
Unit = OTSG
Parent Organization = HSC
Folder Title = DESERT SHIELD MEDICAL ISSUES REVIEW AND AD HOC WORKING GROUP
Folder Seq # = 31
Subject = DESERT SHIELD MEDICAL ISSUES REVIEW AND AD HOC W
Document Seq # = 1
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 04-NOV-1996